Subsidiary of Shanghai Kehua Bio-engineering (002022.SZ) obtains a medical device registration certificate.
Kohwa Biological (002022.SZ) announced that its wholly-owned subsidiary Kohwa (Xi'an) Biotechnology Co., Ltd. has received a medical device registration certificate from the Drug Administration of Shaanxi Province for its product named: Fully Automated Chemiluminescence Immunoassay Analyzer.
Shanghai Kehua Bio-engineering (002022.SZ) announced that its wholly-owned subsidiary, Kehua (Xi'an) Bioengineering Co., Ltd., has received a medical device registration certificate issued by the Shaanxi Provincial Food and Drug Administration. The product name is: Fully automated chemiluminescence immunoassay analyzer.
Related Articles
WING ON CO (00289) spent 13,100 Hong Kong dollars to buy back 1000 shares on December 9th.
CBK Holdings (08428) subsidiary reached a strategic cooperation with Shanxi Weizhangmen, which is a key measure to develop the Chinese market and achieve long-term sustainable development.
FOUNDER HOLD (00418) repurchased 48,000 shares for 38,900 Hong Kong dollars on December 9th.
WING ON CO (00289) spent 13,100 Hong Kong dollars to buy back 1000 shares on December 9th.
CBK Holdings (08428) subsidiary reached a strategic cooperation with Shanxi Weizhangmen, which is a key measure to develop the Chinese market and achieve long-term sustainable development.
FOUNDER HOLD (00418) repurchased 48,000 shares for 38,900 Hong Kong dollars on December 9th.
RECOMMEND
Baidu’s AI Ace Kunlunxin Prepares For Hong Kong IPO, Domestic Computing Power Faces Crucial Test
08/12/2025
Institutions Say Short-Term Volatility Does Not Alter Upward Trend Of Hong Kong Stocks, Hang Seng Index Still Expected To Challenge 30,000 Points Next Year
08/12/2025
As The 2025 Central Economic Work Conference Approaches, What New Expectations Lie Ahead For Next Year’s Economic Agenda? Institutions Forecast Five Key Highlights
08/12/2025
